These Analysts Revise Their Forecasts On Abbott Following Q2 Results

Abbott Laboratories ABT reported better-than-expected sales and profits in the second quarter, but dialed back earnings and growth projections for the rest of the year.The company reported second-quarter sales of $11.14 billion, beating the consensus of $11.07 billion. The U.S. MedTech giant reported adjusted earnings of $1.26, beating the consensus of $1.25, and within the management guidance of $1.23-$1.27."Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS gro ...